Molecular differences between small and large cells in patients with chronic lymphocytic leukemia
Fancis Giles
Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Search for more papers by this authorSusan O'Brien
Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Search for more papers by this authorHagop M. Kantarjian
Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Search for more papers by this authorMichael J. Keating
Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Search for more papers by this authorMaher Albitar
Departments of Hematopathology and
Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Search for more papers by this authorFancis Giles
Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Search for more papers by this authorSusan O'Brien
Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Search for more papers by this authorHagop M. Kantarjian
Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Search for more papers by this authorMichael J. Keating
Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Search for more papers by this authorMaher Albitar
Departments of Hematopathology and
Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Search for more papers by this authorThis work was supported in part by the CRC PO1CA81534.
Abstract
Abstract: The genetic events involved in the transformation of chronic lymphocytic leukemia (CLL) to Richter's syndrome (RS) are poorly understood. Frequently large cells are seen in the bone marrows of patients with CLL and evidence of RS. Using a laser-capture microdissection we analyzed small and large leukemic bone marrow cells from 19 patients with RS for loss of heterozygosity (LOH) on chromosome 11 (D11S2179 at the ATM gene), 17 (D17S938 and D17S1852 at the TP53 site), and 20 (Plc1, D20S96, D20S110, and D20S119). Megakaryocytes were also isolated and used as a control for normal cells. Four of 15 (27.7%) informative cases showed LOH in small cells in the ATM gene while seven (46.7%) showed LOH in large cells. Six of 15 (40%) informative cases had LOH in chromosome 17 in small cells, and eight (53%) showed LOH in large cells. Eleven of 19 informative cases (61.1%) showed LOH in chromosome 20 in large cells, and eight (42.1%) showed LOH in small cells. RS cases with LOH at chromosome 20 were associated with marginally shorter survival rates (P = 0.08). Our data suggest that there are significant molecular differences between large and small cells in patients with CLL. Further analysis of the genes on these chromosomes may provide new insight into our understanding of the transformation of small CLL cells to large (Richter) cells.
References
- 1 O'Brien S, del Giglio A, Keating M. Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood 1995; 85: 307–318.
- 2 Keating MJ. Chronic lymphocytic leukemia. Semin Oncol 1999; 26: 107–114.
- 3 Foucar K, Rydell RE. Richter's syndrome in chronic lymphocytic leukemia. Cancer 1979; 46: 118–134.
- 4 Robertson LE, Pugh W, O'Brien S, Kantarjian H, Hirsch-Ginsberg C, Cork A, McLaughlin P, Cabanillas F, Keating MJ. Richter's syndrome: a report on 39 patients. J Clin Oncol 1993; 11: 1985–1989.
- 5 Giles FJ, O'Brien S, Keating MJ. Chronic lymphocytic leukemia in (Richter's) transformation. Semin Oncol 1998; 25: 117–125.
- 6 Koduru PR, Lichman SM, Smilari TF, Sun T, Goh JC, Karp L, Hall W, Hashimoto S, Chiorazzi N, Broome JD. Serial phenotypic, cytogenetic and molecular genetic studies in Richter's syndrome: demonstration of lymphoma development from the chronic lymphocytic leukemia. Br J Haematol 1993; 85: 613–616.
- 7 Harris JE. Transformation of chronic lymphocytic leukemia to immunoblastic lymphoma (Richter's syndrome). Med Pediatr Oncol 1997; 29: 146–151.
- 8 Medeiros LJ, Stetler-Stevenson MA. Composite B-cell and T-cell lymphoma. Coincidental occurrence or related neoplasm?. Am J Clin Pathol 1992; 98: 387–389.
- 9 Foon KA, Thiruvengadam R, Saven A, Bernstein ZP, Gale RP. Genetic relatedness of lymphoid malignancies. Transformation of chronic lymphocytic leukemia as a model. Ann Intern Med 1993; 119: 63–73.
- 10 Matolcsy A, Inghirami G, Knowles DM. Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma. Blood 1994; 83: 1363–1372.
- 11 Gaidano G, Ballerini P, Gon JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Dalla-Favera R. R.p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1991; 88: 5413–5417.
- 12 Cobo F, Pinyol M, Bosch F. Analysis of cyclin-dependent kinase inhibitors (CDK1) and p53 in chronic lymphocytic leukemia (CLL): mutations of p53 and deletions of p16INK4A genes are associated with Richter's syndrome (RS). Hematol Cell Ther 1997; 39: 65[abstract].
- 13 Fenaux P, Preudhomme C, Lai JL, Quiquandon I, Jonveaux P, Vanrumbeke M, Sartiaux C, Morel P, Loucheux-Lefebvre MH, Bauters F. Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis. Leukemia 1992; 6: 246–250.
- 14 Amiel A, Arbov L, Manor Y. Monoallelic p53 deletion in chronic lymphocytic leukemia detected by interphase cytogenetics. Cancer Genet Cytogenet 1997; 97: 97–100.
- 15 Dierlamm J, Michaux L, Criel A, Wlodarska I, Van Berghe den H, Hossfeld DK. Genetic abnormalities in chronic lymphocytic leukemia and their clinical and prognostic implications. Cancer Genet Cytogenet 1997; 94: 27–35.
- 16 Lens D, De Schouwer PJ, Hamoudi RA. p53 abnormalities in B-cell prolymphocytic leukemia. Blood 1997; 89: 2015–2023.
- 17 Stilgenbauer S, Dohner K, Bentz M, Lichter P, Dohner H. Molecular cytogenetic analysis of B-cell chronic lymphocytic leukemia. Ann Hematol 1998; 76: 101–100.
- 18 Volpe G, Gamberi B, Pastore C, Roetto A, Pautasso M, Parvis G, Camaschella C, Mazza U, Saglio G, Gaidano G. Analysis of microsatellite instability in chronic lymphoproliferative disorders. Ann Hematol 1996; 72: 67–71.
- 19 Starostik P, Manshouri T, O'Brien S, Freireich E, Kantarjian H, Haidar M, Lerner S, Keating M, Albitar M. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia. Cancer Res 1998; 58: 4552–4557.
- 20 Schaffner C, Stilgenbauer S, Rappold GA, Dohner H, Lichter P. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood 1999; 94: 748–753.
- 21 Auer RL, Jones C, Mullenbach RA, Syndercombe-Court D, Milligan DW, Fegan CD, Cotter FE. Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia. Blood 2001; 97: 509–515.
- 22 Bonner RF, Emmert-Buck M, Cole K, Pohida T, Chuaqui R, Goldstein S, Liotta LA. Laser capture microdissection: molecular analysis of tissue. Science 1997; 278: 1481–1483.
- 23 Suarez-Quian CA, Goldstein SR, Pohida T, Smith PD, Peterson JI, Wellner E, Ghany M, Bonner RF. Laser capture microdissection of single cells from complex tissue. Biotechniques 1999; 26: 328–335.
- 24
Milchgrub S,
Wistuba I,
Kim BK,
Rutherford C,
Urban J,
Cruz PD, Jr,
Gazdar AF.
Molecular identification of metastatic cancer to the skin using laser capture microdissection.
Cancer
2000; 88: 749–754.
10.1002/(SICI)1097-0142(20000215)88:4<749::AID-CNCR3>3.0.CO;2-9 CAS PubMed Web of Science® Google Scholar
- 25 Juliusson G, Oscier D, Gahrton G for the International Working Party on Chromosomes in CLL (IWCCLL). Cytogenetic finding and survival in B-cell chronic lymphocytic leukemia. Second IWCCLL compilation of data on 662 patients. Luk Lymphoma 1991; 5: 21–25.
- 26 Kipps TJ. Genetics of chronic leukemia. Hematol Cell Ther 2000; 42: 5–14.
- 27 Dohner H, Stilgenbauer S, Dohner K, Bentz M, Lichter P. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J Mol Med 1999; 77: 266–281.
- 28 Bea S, Lopez-Guillermo A, Ribas M, Puig X, Pinyol M, Carrio A, Zamora L, Soler F, Bosch F, Stilgenbauer S, Colomer D, Miro R, Montserrat E, Campo E. Related Articles, Links Abstract Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome). Am J Pathol. 2002; 161: 957–968.
- 29 Davis MP, Dewald GW, Pierre RV, Hoagland HC. Hematologic manifestations associated with deletions of the long arm of chromosome 20. Cancer Genet Cytogenet 1984; 12: 63–71.
- 30 Kurtin PJ, Dewald GW, Shields DJ, Hanson CA. Hematologic disorders associated with deletions of chromosome 20q. Am J Clin Pathol 1996; 106: 680–688.
- 31 Aatola M, Armstrong E, Teerenhovi L, Borgstrom GH. Clinical significance of the del(20q) in hematologic disorders. Cancer Genet Cytogenet 1992; 62: 75–80.
- 32 Mori N, Morosetti R, Hoflehner E, Lubbert M, Mizoguchi H, Koeffler HP. Allelic loss in progression of myelodysplastic syndrome. Cancer Res 2000; 60: 3039–3042.
- 33 Roulston D, Espinosa R III, stoffel m, bell gl, le beau MM. Molecular genetics of myeloid leukemia: identification of the commonly deleted segment of chromosome 20. Blood 1993; 82: 3424–3429.
- 34
Wang PW,
Iannatuoni K,
Davis EM,
Espinosa R, III,
Stoffel M,
Le Beau MM.
Refinement of the commonly deleted segment in myeloid leukemias with a del(20q).
Genes Chromosomes Cancer
1998; 21: 75–81.
10.1002/(SICI)1098-2264(199802)21:2<75::AID-GCC1>3.0.CO;2-4 CAS PubMed Web of Science® Google Scholar
- 35 Couque N, Chambon-Pautas C, Cave H, Bardet V, Duval M, Vilmer E, Grandchamp B. Mapping of chromosome 20q for loss of heterozygosity in childhood ALL reveals a 1000-kb deletion in one patient. Leukemia 1999; 13: 1972–1974.
- 36 Hollings PE, Benjes SM, Rosman I, Fitzgerald PH. Deletion 20q in association with Philadelphia chromosome positive acute lymphoblatic leukemia. Cancer Genet Cytogenet 1995; 79: 32–35.
- 37 Lavin MF, Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu Rev Immunol 1997; 15: 177–182.
- 38 Jeggo PA, Carr AM, Lehmann AR. Splitting the ATM: distinct repair and checkpoint defects in ataxia telangiectasia. Trends Genet 1998; 14: 312–318.
- 39 Stankovic T, Kidd AMJ, Sutcliffe A, McGuire GM, Robinson P, Weber P, Bedenham T, Bradwell AR, Easton DF, Lennox GG, Haites N, Byrd PJ, Taylor AM. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 1998; 62: 334–345.
- 40 Fegan C, Robinson H, Thompson P. Karyotypic evolution in CLL: identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease. Leukemia 1995; 9: 2003–2008.
- 41 Dohner H, Stilgenbauer S, James MR, Benner A, Weilguni T, Bentz M, Fischer K, Hunstein W, Lichter P. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 1997; 89: 2516–2522.
- 42 Bullrich F, Rasio D, Kitada S, Starostik P, Kipps T, Keating M, Albitar M, Reed JC, Croce CM. ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res 1999; 59: 24–27.
- 43 Bevan S, Yuille MR, Marossy A, Catovsky D, Houston RS. Ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukemia. Lancet 1999; 353: 26–29.
- 44
Haidar MA,
Kantarjian H,
Manshouri T,
Chang CY,
O'Brien S,
Freireich E,
Keating M,
Albitar M.
ATM gene deletion in patients with adult acute lymphoblastic leukemia.
Cancer
2000; 88: 1057–1062.
10.1002/(SICI)1097-0142(20000301)88:5<1057::AID-CNCR16>3.0.CO;2-6 CAS PubMed Web of Science® Google Scholar